Japanese biotech startups are entering a new phase of commercial and scientific growth. Long recognized for strengths in pharmaceuticals, regenerative medicine and academic research, Japan is now producing a broader pipeline of biotechnology companies focused on next-generation therapeutics, gene editing and AI-supported drug discovery.
THANK YOU FOR SUBSCRIBING



